Canada markets open in 1 hour 15 minutes

Chugai Pharmaceutical Co., Ltd. (CHGCY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
15.29+0.07 (+0.46%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 50.36B
Enterprise Value 45.50B
Trailing P/E 24.25
Forward P/E 22.57
PEG Ratio (5 yr expected) 6.83
Price/Sales (ttm)7.64
Price/Book (mrq)4.82
Enterprise Value/Revenue 6.90
Enterprise Value/EBITDA 16.11

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 35.09%
S&P500 52-Week Change 323.33%
52 Week High 322.61
52 Week Low 313.26
50-Day Moving Average 316.56
200-Day Moving Average 317.08

Share Statistics

Avg Vol (3 month) 3183.96k
Avg Vol (10 day) 3104.2k
Shares Outstanding 53.29B
Implied Shares Outstanding 63.29B
Float 8639.35M
% Held by Insiders 10.00%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.27
Forward Annual Dividend Yield 41.76%
Trailing Annual Dividend Rate 380.00
Trailing Annual Dividend Yield 3525.62%
5 Year Average Dividend Yield 41.65
Payout Ratio 438.83%
Dividend Date 3Sept 16, 2019
Ex-Dividend Date 4Dec 28, 2023
Last Split Factor 212:1
Last Split Date 3Jul 06, 2020

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 31.50%
Operating Margin (ttm)42.15%

Management Effectiveness

Return on Assets (ttm)15.01%
Return on Equity (ttm)21.20%

Income Statement

Revenue (ttm)1.04T
Revenue Per Share (ttm)314.86
Quarterly Revenue Growth (yoy)-24.10%
Gross Profit (ttm)N/A
EBITDA 472.39B
Net Income Avi to Common (ttm)326.37B
Diluted EPS (ttm)0.63
Quarterly Earnings Growth (yoy)1.20%

Balance Sheet

Total Cash (mrq)764.57B
Total Cash Per Share (mrq)464.67
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.53
Book Value Per Share (mrq)997.97

Cash Flow Statement

Operating Cash Flow (ttm)383.09B
Levered Free Cash Flow (ttm)287.01B